UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000015835 |
|---|---|
| Receipt number | R000018427 |
| Scientific Title | Cetuximab plus S-1 and irinotecan (IRIS) as first-line treatment in RAS wild type metastatic colorectal cancer, a phase I/II trial (KSCC1401) |
| Date of disclosure of the study information | 2014/12/03 |
| Last modified on | 2019/03/01 17:07:30 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/12/03 20:09:25 | ||
| 2 | Update | 2014/12/04 14:29:57 | UMIN ID1 |
|
| 3 | Update | 2015/05/22 08:14:50 | Email |
|
| 4 | Update | 2015/06/04 08:28:55 | Institutions |
|
| 5 | Update | 2015/07/06 08:30:52 | Institutions |
|
| 6 | Update | 2015/12/03 10:11:19 | Institutions |
|
| 7 | Update | 2016/02/24 19:01:32 | Acronym Acronym |
|
| 8 | Update | 2016/06/03 09:34:29 | Name of primary person or sponsor Organization Institutions |
|
| 9 | Update | 2016/07/04 09:51:44 | Institutions |
|
| 10 | Update | 2016/11/23 15:03:34 | Public title Public title Acronym Acronym |
|
| 11 | Update | 2016/11/23 15:07:33 | Interventions/Control_1 Key inclusion criteria Key inclusion criteria |
|
| 12 | Update | 2016/12/04 11:03:15 | Institutions |
|
| 13 | Update | 2016/12/31 13:10:04 | Narrative objectives1 Narrative objectives1 |
|
| 14 | Update | 2017/06/05 10:22:44 | Institutions |
|
| 15 | Update | 2019/01/06 17:16:37 | Recruitment status |
|
| 16 | Update | 2019/01/06 17:17:04 | Email |
|
| 17 | Update | 2019/03/01 17:07:30 | Recruitment status Publication of results |
